These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21707797)

  • 21. Anti-KEL7 (anti-Js(b)) alloimmunization diagnostic supported by molecular KEL*6,7 typing in a pregnant woman with previous intrauterine deaths.
    Boturão-Neto E; Chiba AK; Oliveira Barros MM; Barretto de Mello A; Fabron A; Orlando Bordin J
    Transfus Apher Sci; 2006 Dec; 35(3):217-21. PubMed ID: 17097348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Basis of KELnull Phenotype in Brazilians.
    Boturão-Neto E; Yamamoto M; Chiba AK; Kimura EY; de Oliveira Mdo C; do Monte Barretto CL; Nunes MM; Albuquerque SR; de Deus Santos MD; Bordin JO
    Transfus Med Hemother; 2015 Jan; 42(1):52-8. PubMed ID: 25960716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis-modifier effect of KEL3.
    Körmöczi GF; Scharberg EA; Gassner C
    Transfusion; 2009 Apr; 49(4):733-9. PubMed ID: 19347978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel
    Yearout S; Smith A; Keller J; Keller MA
    Immunohematology; 2022 Jul; 38(2):51-54. PubMed ID: 35852066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Dinardo CL; Oliveira TGM; Kelly S; Ashley-Koch A; Telen M; Schmidt LC; Castilho S; Melo K; Dezan MR; Wheeler MM; Johnsen JM; Nickerson DA; Jain D; Custer B; Pereira AC; Sabino EC;
    Transfusion; 2021 Feb; 61(2):603-616. PubMed ID: 33231305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Another example of a KEL1 variant red cell phenotype due to a threonine to serine change at position 193 of Kell glycoprotein.
    Lee-Stroka H; Slezak SL; Adams S; Martin J; Robbins FM; Caruccio L; Byrne KM; Stroncek DF
    Transfusion; 2008 May; 48(5):925-9. PubMed ID: 18248571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A KEL*02mod allele responsible for an apparent maternity exclusion].
    Monfort M; Peyrard T; Arnaud L; Helias V; Maggipinto G; Gérard C
    Transfus Clin Biol; 2013 Dec; 20(5-6):490-5. PubMed ID: 23727116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic analyses of KEL alleles in alloimmunized thalassemia patients from Iran.
    Reyhaneh S; Naser A; Arezoo O
    Transfus Apher Sci; 2020 Oct; 59(5):102840. PubMed ID: 32565058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An autoanti-Kp b immunoglobulin M that simulates antigen suppression.
    Bosco A; Xenocostas A; Kinney J; Cadwell CM; Zimring JC
    Transfusion; 2009 Apr; 49(4):750-6. PubMed ID: 19170996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New KEL*01M and KEL*02M alleles: structural modeling to assess the impact of amino acid changes.
    Silvy M; Callebaut I; Filosa L; Granier T; Chiaroni J; Bailly P
    Transfusion; 2016 May; 56(5):1223-9. PubMed ID: 26996808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silent KEL alleles identified from Japanese individuals with the K
    Onodera T; Kawai M; Obara K; Enomoto T; Sasaki K; Osabe T; Ogasawara K; Toyoda C; Tsuneyama H; Uchikawa M; Inaba S; Satake M
    Vox Sang; 2018 Apr; 113(3):290-296. PubMed ID: 29280152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells.
    Daniels GL; Weinauer F; Stone C; Ho M; Green CA; Jahn-Jochem H; Offner R; Monaco AP
    Blood; 1996 Nov; 88(10):4045-50. PubMed ID: 8916972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point mutations in KEL exon 8 determine a high-incidence (RAZ) and a low-incidence (KEL25, VLAN) antigen of the Kell blood group system.
    Lee S; Reid ME; Redman CM
    Vox Sang; 2001 Nov; 81(4):259-63. PubMed ID: 11904003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of a novel missense mutation found in the A4GALT gene of Amish individuals with the p phenotype.
    Hellberg A; Schmidt-Melbye AC; Reid ME; Olsson ML
    Transfusion; 2008 Mar; 48(3):479-87. PubMed ID: 18067504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First report of a KELnull phenotype in Peru and a lesson of invisible genetic disparity.
    Pérez I; Castilho L; Goytendia A; Rojas E; Bernal J; Alva J; Coyotupac J; Cortez C; Munive C; Tirado-Hurtado I; Pinto JA
    Transfus Apher Sci; 2019 Aug; 58(4):453-456. PubMed ID: 31176642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of KEL*01 and KEL*02 Genotyping to Recruit Uncommon, Kell-positive, Reagent Red Cells Among Thai Blood Donors.
    Intharanut K; Khantisitthiporn O; Kupatawintu P; Leetrakool N; Mitundee S; Nathalang O
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The KEL24 and KEL14 alleles of the Kell blood group system.
    Lee S; Naime D; Reid M; Redman C
    Transfusion; 1997 Oct; 37(10):1035-8. PubMed ID: 9354821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene (Kel).
    Zhu X; Rivera A; Golub MS; Peng J; Sha Q; Wu X; Song X; Kumarathasan P; Ho M; Redman CM; Lee S
    Am J Hematol; 2009 Aug; 84(8):492-8. PubMed ID: 19544475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of two novel and related high-prevalence antigens in the Kell blood group system, KUCI and KANT, and their serologic and spatial association with K11 and KETI.
    Velliquette RW; Hue-Roye K; Lomas-Francis C; Gillen B; Schierts J; Gentzkow K; Peyrard T; von Zabern I; Flegel WA; Rodberg K; Debnath AK; Lee S; Reid ME
    Transfusion; 2013 Nov; 53(11 Suppl 2):2872-81. PubMed ID: 23560718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.